论文部分内容阅读
近年来随着影像技术不断进步,成像形式从反映病变解剖结构发展到反映病变代谢及功能特征。18F-脱氧葡萄糖(18F-FDG)PET/CT显像作为分子成像的重要组成,已在临床逐步应用,尤其广泛应用于妇科常见肿瘤宫颈癌中。大量临床应用表明,PET/CT具有更准确的临床分期能力,能更早地判断治疗疗效响应、监测复发和残留肿瘤,以更好地判断预后,较CT和MRI展示出巨大优势和前景。
In recent years, with the continuous improvement of imaging technology, the imaging modality reflects the development of the anatomic structure of the lesion to reflect the metabolic and functional characteristics of the lesion. 18F-FDG PET / CT imaging as an important component of molecular imaging, has been gradually applied in clinical practice, especially widely used in gynecological cervical cancer. A large number of clinical applications show that PET / CT has a more accurate clinical staging ability to be able to earlier determine the response to treatment efficacy, monitoring recurrence and residual tumor to better determine the prognosis, compared with CT and MRI showed great advantages and prospects.